Dr Steidl is the Research Director of the Centre for Lymphoid Cancer (CLC) at BC Cancer and Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia in Canada. His expertise are clinical malignant hematology, molecular pathology, genomics and lymphoma biology. Dr Steidl’s research focuses on the pathogenesis of B cell lymphomas, tumor microenvironment biology and applied genomics. Dr Steidl contributed to the discovery of novel somatic gene mutations in B cell lymphomas using next generation sequencing and established tumor microenvironment composition as novel biomarkers for outcome prediction in Hodgkin lymphoma. His leading role in the CLC, associated membership to BCC’s Lymphoma Tumor Group as well as active collaborations with scientific consortia and clinical trials groups enable the use of primary biopsy material as the start and end points of discovery and biomarker studies in his lymphoma program promoting precision oncology.